InsidersTradesSigma
窪田製薬ホールディングス株式会社 Stock: price and directors' dealings · Japan · EDINET (Japan FSA)
Follow the 窪田製薬ホールディングス株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 窪田製薬ホールディングス株式会社 has published 59 insider filings. Market capitalisation: €9.8bn. The latest transaction was filed on 8 July 2026 (Holding update). Among the most active insiders: Barclays Bank PLC. Every trade is free.
59
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
13Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,515 of 26,270 companies
11.9
score / 100
Value20
Quality4
FCF yld-5.7%
Earn yld-6.5%
EV/EBITDA·
ROE-51%
Gross mgn-22%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 8 July 2026
Declarations59 total
22.8% of flowShareXTKSEDINET:S100XCN4
32.8% of flowShareXTKSEDINET:S100XC52
ShareXTKSEDINET:S100WTQW
ShareXTKSEDINET:S100WO1E
0.0% of flowShareXTKSEDINET:S100WO1N
25 of 59 declarations
About 窪田製薬ホールディングス株式会社
Kubota Pharmaceutical Holdings Co., Ltd. is a Japanese company focused on the health and pharmaceutical sector. It specializes in the development of innovative treatments and therapeutic solutions.